J R Guthrie1, L Dennerstein, J L Hopper, H G Burger. 1. Key Centre for Women's Health Services, Department of Public Health and Community Medicíne, University of Melbourne, Carlton, Australia.
Abstract
OBJECTIVE: To determine the frequency of hot flushes in a population sample of 453 pre-, peri-, and postmenopausal women (aged 48-59 years), and to investigate the relationship of hot-flush reporting with menstrual status, serum levels of estradiol (E2), inhibin, and FSH, history of premenstrual complaints, and physical and life-style factors. METHODS: We used a population-based sample. Interviews were conducted in the women's homes. RESULTS: Frequency of hot-flush reporting was associated with menstrual status (P < .001). Twenty-nine percent of women who had more than 3 and less than 12 months of amenorrhea, and 37% of postmenopausal women experienced hot flushes several times a day. In total, 13% of premenopausal women, 37% of perimenopausal women, 62% of postmenopausal women, and 15% of women on hormone therapy reported having had at least one hot flush in the previous 2 weeks. Follicle-stimulating hormone levels were higher in women who experienced hot flushes at least once a day or more (P < .001); E2 levels were higher in women experiencing one or no hot flushes per week (P < .001). The women in the perimenopausal group who experienced hot flushes had higher FSH levels (P = .008) and were more likely to have reported premenstrual complaints at the first interview 3 years earlier (P = .03). In the postmenopausal group, there was no significant difference with any of the variables studied between the women who were experiencing hot flushes and those who were not. CONCLUSION: Reporting of hot flushes is greatest 3 months or more after the final menstrual period. The frequency of hot flushes is associated with increasing FSH, decreasing E2, and a history of premenstrual complaints.
OBJECTIVE: To determine the frequency of hot flushes in a population sample of 453 pre-, peri-, and postmenopausal women (aged 48-59 years), and to investigate the relationship of hot-flush reporting with menstrual status, serum levels of estradiol (E2), inhibin, and FSH, history of premenstrual complaints, and physical and life-style factors. METHODS: We used a population-based sample. Interviews were conducted in the women's homes. RESULTS: Frequency of hot-flush reporting was associated with menstrual status (P < .001). Twenty-nine percent of women who had more than 3 and less than 12 months of amenorrhea, and 37% of postmenopausal women experienced hot flushes several times a day. In total, 13% of premenopausal women, 37% of perimenopausal women, 62% of postmenopausal women, and 15% of women on hormone therapy reported having had at least one hot flush in the previous 2 weeks. Follicle-stimulating hormone levels were higher in women who experienced hot flushes at least once a day or more (P < .001); E2 levels were higher in women experiencing one or no hot flushes per week (P < .001). The women in the perimenopausal group who experienced hot flushes had higher FSH levels (P = .008) and were more likely to have reported premenstrual complaints at the first interview 3 years earlier (P = .03). In the postmenopausal group, there was no significant difference with any of the variables studied between the women who were experiencing hot flushes and those who were not. CONCLUSION: Reporting of hot flushes is greatest 3 months or more after the final menstrual period. The frequency of hot flushes is associated with increasing FSH, decreasing E2, and a history of premenstrual complaints.
Authors: Laura B Harrington; Marc Blondon; Mary Cushman; Andrew M Kaunitz; Jacques E Rossouw; Matthew A Allison; Lisa W Martin; Karen C Johnson; Jan Rosing; Nancy F Woods; Andrea Z LaCroix; Susan R Heckbert; Barbara McKnight; Nicholas L Smith Journal: Menopause Date: 2017-04 Impact factor: 2.953
Authors: H Irene Su; Mary D Sammel; Erin Springer; Ellen W Freeman; Angela DeMichele; Jun J Mao Journal: Breast Cancer Res Treat Date: 2010-02-25 Impact factor: 4.872
Authors: Matthew A Allison; Joann E Manson; Aaron Aragaki; Robert D Langer; Jacques Rossouw; David Curb; Lisa W Martin; Lawrence Phillips; Marcia L Stefanick; Barbara B Cochrane; Gloria Sarto; Janice Barnhart; Mary Jo O'Sullivan; Karen C Johnson; Margery Gass; Maurizio Trevisan; Nancy F Woods Journal: Menopause Date: 2010 Nov-Dec Impact factor: 2.953
Authors: L B Harrington; M Blondon; M Cushman; A M Kaunitz; M A Allison; L Wang; S Sullivan; N F Woods; A Z LaCroix; S R Heckbert; B McKnight; J Rossouw; N L Smith Journal: J Thromb Haemost Date: 2018-04-02 Impact factor: 5.824
Authors: Yi Huang; Kathleen E Malone; Kara L Cushing-Haugen; Janet R Daling; Christopher I Li Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-06 Impact factor: 4.254
Authors: Kristine E Ensrud; Joseph C Larson; Katherine A Guthrie; Carolyn J Crandall; Andrea Z LaCroix; Susan D Reed; Shalender Bhasin; Caroline M Mitchell; Hadine Joffe Journal: Menopause Date: 2022-08-16 Impact factor: 3.310
Authors: Lisa Gallicchio; Chrissy Schilling; William A Romani; Susan Miller; Howard Zacur; Jodi A Flaws Journal: Maturitas Date: 2008-03-04 Impact factor: 4.342
Authors: Joanne Ryan; Henry G Burger; Cassandra Szoeke; Philippe Lehert; Marie-Laure Ancelin; Victor W Henderson; Lorraine Dennerstein Journal: Menopause Date: 2009 May-Jun Impact factor: 2.953